Sector: MedicalAnika Therapeutics Inc. (NASDAQ: ANIK)
Headlines
- Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Nov 19, 2009 08:30 AM | ANIK
- Anika Therapeutics Reports 17% Revenue Growth in Third-Quarter 2009
Oct 27, 2009 04:05 PM | ANIK
- Anika Therapeutics Announces Date of Third Quarter 2009 Financial Results Conference Call
Oct 13, 2009 04:15 PM | ANIK
- Anika Therapeutics Receives Health Canada Approval for MONOVISC(TM)
Aug 20, 2009 09:24 AM | ANIK, HBP
- TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Jun 30, 2008 10:30 AM | ANIK, CXM, RGEN
- NASDAQ Technical Picture - High Volume Drubbing
Jul 24, 2007 09:17 PM | AAPL, AFL, ALAB, AMZN, ANAD, ANGO
- MOVERS & SHAKERS: Friday's Biggest Stock Gainers And Decliners
Apr 13, 2007 02:53 PM | ANIK, CBS, CBUK, COT, DJ, DYAX
- NovaDel Pharma Says Partner Hana Biosciences Files Zensana Application With FDA and Anika Therapeutics Announces Worldwide Development and Commercialization Agreement with Galderma Pharma
Jul 05, 2006 01:01 PM | ANIK, CEGE, NVD
- Anika Therapeutics Reports Second-Quarter 2009 Results
Jul 22, 2009 04:53 PM | ANIK
- Anika Therapeutics Announces Date of Second Quarter 2009 Financial Results Conference Call
Jul 15, 2009 04:17 PM | ANIK
- Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
Jul 06, 2009 05:46 AM | ANIK
- Anika Therapeutics Announces U.S. Distribution Agreement with Facial Aesthetics Provider Coapt Systems for Aesthetic Dermatology Franchise
Jun 08, 2009 08:42 AM | ANIK
- Anika Therapeutics Appoints Frank J. Luppino as Chief Operating Officer
May 26, 2009 04:06 PM | ANIK
- Anika Therapeutics Reports First Quarter 2009 Results
Apr 29, 2009 05:52 PM | ANIK
- Anika Therapeutics Reports Record Revenue for 2008
Mar 05, 2009 05:16 PM | ANIK
- Anika Therapeutics Announces Date of Fourth Quarter and Year End 2008 Financial Results Conference Call
Feb 25, 2009 10:48 AM | ANIK
- Anika Therapeutics to Webcast Presentation at Canaccord Adams Musculoskeletal Conference
Feb 19, 2009 04:11 PM | ANIK
- Anika Therapeutics to Present at Canaccord Adams Musculoskeletal Conference
Jan 08, 2009 09:21 AM | ANIK
- Form 4 LUPPINO FRANCESCO J For: May 26 (10K)
May 27, 2009 07:42 PM
- Form 3 LUPPINO FRANCESCO J For: May 26 (10K)
May 27, 2009 07:40 PM
- Form 4 QUINLAN KEVIN W For: Mar 27 (10K)
Mar 30, 2009 06:24 PM
- Form 4 LAND RAYMOND J For: Mar 02 (10K)
Mar 03, 2009 07:47 PM
- Form 4 Moran John C For: Mar 02 (10K)
Mar 03, 2009 07:47 PM
- Form 4 DAVIDSON EUGENE A For: Mar 02 (10K)
Mar 03, 2009 07:47 PM
- Form 4 WHEELER STEVE E For: Mar 02 (10K)
Mar 03, 2009 07:47 PM
- Form 4 BOWER JOSEPH I For: Mar 02 (10K)
Mar 03, 2009 07:47 PM
- Form 4 QUINLAN KEVIN W For: Mar 02 (10K)
Mar 03, 2009 07:45 PM
- Form 4 SHERWOOD CHARLES H For: Mar 02 (10K)
Mar 03, 2009 07:45 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ANIK
|
Compare to S&P
|
| YTD |
164.15 %
|
118.61 %
|
| 4 Weeks |
27.87 %
|
26.49 %
|
| 12 Weeks |
32.95 %
|
25.34 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 62.50 %
|
|
EPS Growth in Last Year: 30.00 %
|
|
Sales Growth in Last Quarter: 13.32 %
|
|
Sales Growth in Last Quarter: 17.25 %
|
|
